, Tracking Stock Market Picks
Enter Symbol:
Astrazeneca Plc (AZN) [hlAlert]

down 6.81 %

Astrazeneca Plc (AZN) rated Buy by Bryan Garnier

Posted on: Friday,  Sep 18, 2015  10:25 AM ET by Bryan Garnier

Bryan Garnier rated Buy Astrazeneca Plc (NYSE: AZN) on 09/18/2015, when the stock price was $33.92. Since
then, Astrazeneca Plc has lost 6.81% as of 01/19/2016's recent price of $31.61.
If you would have followed this Bryan Garnier's recommendation on AZN, you would have lost 6.81% of your investment in 123 days.

AstraZeneca PLC (AstraZeneca) is engaged in the discovery, development, manufacturing and marketing of prescription pharmaceuticals and biological products for important areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. The Company?s product portfolio comprise: Arimidex, Crestor, Nexium, Seroquel and Symbicort. It has operations in various markets, such as China, United Kingdom, Sweden and the United States. It has 26 manufacturing sites in 18 countries. Cardiovascular product pipeline includes Saxagliptin, Dapagliflozin, Atherosclerosis/dyslipidaemia, Thrombosis and Atrial fibrillation. Gastrointestinal pipeline includes life cycle management initiatives. AstraZeneca?s Infection pipeline MedImmune and Dedicated tuberculosis (TB) research. Oncology product pipeline includes Zactima (vandetanib), Zactima (vandetanib), ZD4054 and MedImmune.

Bryan Garnier
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/18/2015 10:25 AM Buy
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy